INTRODUCTION: Endothelial barrier function is pivotal for the outcome of organ transplantation. Since hypothermic preservation (gold standard) is associated with cold-induced endothelial damage, endothelial barrier function may benefit from organ preservation at warmer temperatures. We therefore assessed endothelial barrier integrity and viability as function of preservation temperature and perfusion solution, and hypothesized that endothelial cell preservation at subnormothermic conditions using metabolism-supporting solutions constitute optimal preservation conditions. METHODS: Human umbilical vein endothelial cells (HUVEC) were preserved at 4-37°C for up to 20 h using Ringer's lactate, histidine-tryptophan-ketoglutarate solution, University of Wisconsin (UW) solution, Polysol, or endothelial cell growth medium (ECGM). Following preservation, the monolayer integrity, metabolic capacity, and ATP content were determined as positive parameters of endothelial cell viability. As negative parameters, apoptosis, necrosis, and cell activation were assayed. A viability index was devised on the basis of these parameters. RESULTS: HUVEC viability and barrier integrity was compromised at 4°C regardless of the preservation solution. At temperatures above 20°C, the cells' metabolic demands outweighed the preservation solutions' supporting capacity. Only UW maintained HUVEC viability up to 20°C. Despite high intracellular ATP content, none of the solutions were capable of sufficiently preserving HUVEC above 20°C except for ECGM. CONCLUSION: Optimal HUVEC preservation is achieved with UW up to 20°C. Only ECGM maintains HUVEC viability at temperatures above 20°C.
INTRODUCTION: Endothelial barrier function is pivotal for the outcome of organ transplantation. Since hypothermic preservation (gold standard) is associated with cold-induced endothelial damage, endothelial barrier function may benefit from organ preservation at warmer temperatures. We therefore assessed endothelial barrier integrity and viability as function of preservation temperature and perfusion solution, and hypothesized that endothelial cell preservation at subnormothermic conditions using metabolism-supporting solutions constitute optimal preservation conditions. METHODS:Human umbilical vein endothelial cells (HUVEC) were preserved at 4-37°C for up to 20 h using Ringer's lactate, histidine-tryptophan-ketoglutarate solution, University of Wisconsin (UW) solution, Polysol, or endothelial cell growth medium (ECGM). Following preservation, the monolayer integrity, metabolic capacity, and ATP content were determined as positive parameters of endothelial cell viability. As negative parameters, apoptosis, necrosis, and cell activation were assayed. A viability index was devised on the basis of these parameters. RESULTS: HUVEC viability and barrier integrity was compromised at 4°C regardless of the preservation solution. At temperatures above 20°C, the cells' metabolic demands outweighed the preservation solutions' supporting capacity. Only UW maintained HUVEC viability up to 20°C. Despite high intracellular ATP content, none of the solutions were capable of sufficiently preserving HUVEC above 20°C except for ECGM. CONCLUSION: Optimal HUVEC preservation is achieved with UW up to 20°C. Only ECGM maintains HUVEC viability at temperatures above 20°C.
Authors: M Ingmar van Raath; Ruud Weijer; Gia Hung Nguyen; Bernard Choi; Anton I de Kroon; Michal Heger Journal: J Biomed Nanotechnol Date: 2016-08 Impact factor: 4.099
Authors: Bote G Bruinsma; James H Avruch; Pepijn D Weeder; Gautham V Sridharan; Basak E Uygun; Negin G Karimian; Robert J Porte; James F Markmann; Heidi Yeh; Korkut Uygun Journal: J Vis Exp Date: 2015-04-27 Impact factor: 1.355
Authors: Ruud Weijer; Séverine Clavier; Esther A Zaal; Maud M E Pijls; Robert T van Kooten; Klaas Vermaas; René Leen; Aldo Jongejan; Perry D Moerland; Antoine H C van Kampen; André B P van Kuilenburg; Celia R Berkers; Simone Lemeer; Michal Heger Journal: Cell Mol Life Sci Date: 2016-11-01 Impact factor: 9.261
Authors: Andrew Scott; Barbara Olack; Joshua D Rouch; Hassan A Khalil; Brent A Kokubun; Nan Ye Lei; Jiafang Wang; Sergio Solorzano; Michael Lewis; James C Y Dunn; Matthias G Stelzner; Joyce C Niland; Martín G Martín Journal: Cell Transplant Date: 2020 Jan-Dec Impact factor: 4.139